The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT01566695 · COMPLETED
Trial details
- NCT number
- NCT01566695
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-26
- Primary completion
- 2019-01-25
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.